JNCE
Jounce Therapeutics, Inc. Common Stock
JNCE
JNCE
Delisted
JNCE was delisted on the 3rd of May, 2023.
84 hedge funds and large institutions have $81.8M invested in Jounce Therapeutics, Inc. Common Stock in 2018 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 31 increasing their positions, 21 reducing their positions, and 16 closing their positions.
Holders
84
Holders Change
-1
Holders Change %
-1.18%
% of All Funds
1.87%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.04%
New
16
Increased
31
Reduced
21
Closed
16
Calls
$18K
Puts
–
Net Calls
+$18K
Net Calls Change
-$3.38M
Top Buyers
Top Sellers
1 |
![]()
1
Fidelity Investments
Boston,
Massachusetts
|
$3.39M |
2 |
CC
2
Casdin Capital
New York
|
$0 |
3 |
3
Millennium Management
New York
|
$735K |
4 |
4
Man Group
London,
United Kingdom
|
$0 |
5 |
5
BlackRock
New York
|
$3.59M |